Clinical Focus

  • Rheumatology

Academic Appointments

Professional Education

  • Board Certification: American Board of Internal Medicine, Rheumatology (2019)
  • Fellowship: University of Miami Jackson Health System Division of Rheumatology (2019) FL
  • Board Certification: American Board of Internal Medicine, Internal Medicine (2017)
  • Residency: University of Miami Miller School of Medicine (2017) FL
  • Residency: Mount Sinai Hospital (2015) IL
  • Medical Education: MediCiti Institute of Medical Sciences (2010) India

Contact

  • Academic
    ramreddy@stanford.edu
    University - Academic staff Department: Medicine - Med/Immunology & Rheumatology Position: Clinical Assistant Professor
  • Clinical (Primary)  Stanford Health Care Tri-Valley 5555 W Las Positas Blvd Pleasanton, CA 94588 (650) 723-3059 (fax)

Additional Clinical Info

All Publications

  • Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis. Arthritis & rheumatology (Hoboken, N.J.) Kass, D. J., Nouraie, M., Glassberg, M. K., Ramreddy, N., Fernandez, K., Harlow, L., Zhang, Y., Chen, J., Kerr, G. S., Reimold, A. M., England, B. R., Mikuls, T. R., Gibson, K. F., Dellaripa, P. F., Rosas, I. O., Oddis, C. V., Ascherman, D. P. 2020; 72 (3): 409-419

    Abstract

    Interstitial lung disease (ILD) is a frequent complication of rheumatoid arthritis (RA), occurring in up to 40% of patients during the course of their disease. Early diagnosis is critical, particularly given the shared clinicoepidemiologic features between advanced rheumatoid arthritis-associated ILD (RA-ILD) and idiopathic pulmonary fibrosis (IPF). This study was undertaken to define the molecular basis of this overlap through comparative profiling of serum proteins in RA-ILD and IPF.Multiplex enzyme-linked immunosorbent assays (ELISAs) were used to profile 45 protein biomarkers encompassing cytokines/chemokines, growth factors, and matrix metalloproteinases (MMPs) in sera obtained from RA patients with ILD and those without, individuals with IPF, and healthy controls. Levels of selected serum proteins were compared between patient subgroups using adjusted linear regression, principal component analysis (PCA), and least absolute shrinkage and selection operator (LASSO) modeling.Multiplex ELISA-based assessment of sera from 2 independent cohorts (Veterans Affairs [VA] and Non-VA) revealed a number of non-overlapping biomarkers distinguishing RA-ILD from RA without ILD (RA-no ILD) in adjusted regression models. Parallel analysis of sera from IPF patients also yielded a discriminatory panel of protein markers in models adjusted for age/sex/smoking, which showed differential overlap with profiles linked to RA-ILD in the VA cohort versus the Non-VA cohort. PCA revealed several distinct functional groups of RA-ILD-associated markers that, in the VA cohort, encompassed proinflammatory cytokines/chemokines as well as 2 different subsets of MMPs. Finally, LASSO regression modeling in the Non-VA and VA cohorts revealed distinct biomarker combinations capable of discriminating RA-ILD from RA-no ILD.Comparative serum protein biomarker profiling represents a viable method for distinguishing RA-ILD from RA-no ILD and identifying population-specific mediators shared with IPF.

    View details for DOI 10.1002/art.41123

    View details for PubMedID 31532072

  • A Curious Case of Acute Respiratory Failure: Is It Antisynthetase Syndrome? Case reports in critical care Malhotra, G., Ramreddy, N., Chua, S., Iliescu, M., Kaur, T. 2016; 2016: 7379829

    Abstract

    Antisynthetase (AS) syndrome is a major subgroup of inflammatory myopathies seen in a minority of patients with dermatomyositis and polymyositis. Although it is usually associated with elevated creatine phosphokinase level, some patients may have amyopathic dermatomyositis (ADM) like presentation with predominant skin involvement. Interstitial lung disease (ILD) is the main pulmonary manifestation and may be severe thereby determining the prognosis. It may rarely present with a very aggressive course resulting in acute respiratory distress syndrome (ARDS). We report a case of a 43-year-old male who presented with nonresolving pneumonia who was eventually diagnosed to have ADM through a skin biopsy without any muscle weakness. ADM may be associated with rapidly progressive course of interstitial lung disease (ADM-ILD) which is associated with high mortality. Differentiation between ADM-ILD and AS syndrome may be difficult in the absence of positive serology and clinical presentation may help in clinching the diagnosis.

    View details for DOI 10.1155/2016/7379829

    View details for PubMedID 27433359

    View details for PubMedCentralID PMC4940527

  • A rare hereditary disease: Muckle-Wells syndrome RHEUMATOLOGY REPORTS Ramreddy, N., Hopkins, A., Lozada, C. 2016; 8 (1): 7-8

    View details for DOI 10.4081/rr.2016.6535

    View details for Web of Science ID 000388227700002